Wilmington Savings Fund Society FSB Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Wilmington Savings Fund Society FSB purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the third quarter, Holdings Channel reports. The fund purchased 1,900 shares of the biotechnology company’s stock, valued at approximately $759,000.

A number of other hedge funds also recently bought and sold shares of the business. Quent Capital LLC raised its stake in shares of Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after buying an additional 75 shares during the period. Prestige Wealth Management Group LLC increased its holdings in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 44 shares in the last quarter. Blue Trust Inc. raised its position in Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after acquiring an additional 79 shares during the period. Brooklyn Investment Group purchased a new position in Axon Enterprise during the third quarter valued at $41,000. Finally, Planning Capital Management Corp grew its position in shares of Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after purchasing an additional 55 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Up 1.3 %

Shares of AXON stock opened at $644.91 on Monday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $241.72 and a twelve month high of $698.67. The company’s 50-day moving average price is $539.52 and its 200-day moving average price is $406.30. The stock has a market cap of $49.17 billion, a price-to-earnings ratio of 166.64, a PEG ratio of 14.19 and a beta of 1.01.

Wall Street Analyst Weigh In

Several research firms recently weighed in on AXON. Northland Securities upped their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. JMP Securities raised their target price on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. The Goldman Sachs Group boosted their price target on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Finally, Robert W. Baird raised their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $488.67.

Insiders Place Their Bets

In related news, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the transaction, the director now directly owns 2,392 shares in the company, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jeri Williams sold 110 shares of Axon Enterprise stock in a transaction on Monday, September 30th. The shares were sold at an average price of $400.00, for a total value of $44,000.00. Following the completion of the sale, the director now owns 1,934 shares in the company, valued at $773,600. This represents a 5.38 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 98,590 shares of company stock valued at $48,795,917 over the last ninety days. Company insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.